Lutein
Natural health product licensed in Canada
- Licence holder
- Flora Manufacturing & Distributing Ltd
- NPN or DIN-HM
- 80006080
- Status
- Active licence
- Licence date
- 10 June 2008
- Revision date
- 29 June 2016
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol Source : Oléorésine de tagetes erecta | 18 mg | Not calculated |
| Vaccinium myrtillus Source : Fruit(s) Extraction ratio : 100:1 Dry plant equivalent : 1,000 mg | 10 mg | Not calculated |
Non-medicinal ingredients
dl-alpha tocophérol, Modified corn starch, Hypromellose, glucose syrup, Carotte, Amidon de maïs, ascorbate de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A blend of antioxidants for the maintenance of eye health. Helps to maintain eyesight in conditions (associated with sunlight damage) such as cataracts and age-related macular degeneration. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density. Clincally proven to help maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Clinically proven to help support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Cinically proven to help improve macular pigment optical density. Clinically proven to help reduce the risk of developing cataracts. Source of antioxidants that help protect cells against the oxidative damage caused by free radicals. Source of antioxidants that help reduce cell damage caused by free radicals. Helps improve macular pigment optical density, which helps protect the eyes (retina) by filtering out the damaging blue light Helps improve macular pigment optical density, which helps to protect the eyes against both blue light and oxidative damage. Helps support eye health by filtering out blue light and reducing oxidative damage. Helps support eye health by filtering out blue light and reducing cell damage caused by free radicals Helps to protect the eyes against both blue light and oxidative damage.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80006080
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging